close and back to page

Johnson & Johnson: Black Panther Actress Danai Gurira Champions Initiative to End HIV/AIDS

She called attention to women across Africa participating in clinical trials for a vaccine.

Actress, playwright and activist Danai Gurira hit the red carpet at the Mandela 100 Global Citizen Festival in Johannesburg before making a powerful and emotional speech at the event spotlighting the women across Africa who are participating in a clinical trial of a Johnson & Johnson vaccine that could help to prevent HIV. "Today, we are much closer to preventing HIV– and that was something none of us could ever have imagined." #makeHIVhistory.

Johnson & Johnson and UNICEF Celebrate #WorldChildrensDay

To celebrate World Children's Day, Johnson & Johnson opened its doors to hold a "press conference" for kids by kids.

Originally Published by Johnson & Johnson.

On World Children's Day, Johnson & Johnson announced the expansion of its global partnership with UNICEF by committing $10 million to support its health programs. This commitment will allow frontline healthcare workers to be properly trained with the most innovative tools to ensure life-saving care to women, newborns and children living in the most vulnerable communities worldwide.

Read More Show Less

Johnson & Johnson Ranks Among Top Companies Worldwide Expanding Access to Medicines

"We are proud of this achievement, but far from complacent."

REUTERS

Originally Published by Johnson & Johnson.

For the fourth consecutive time, Johnson & Johnson has ranked among the top three companies worldwide working to expand access to medicines according to the 2018 Access to Medicines Index. The Index, which was compiled by independent experts at the Access to Medicines Foundation, evaluates 20 of the world's largest research-based pharmaceutical companies on their performance in making medicines, vaccines and diagnostics more accessible to people in need in low- and middle-income countries.

Read More Show Less

Johnson & Johnson Chairman and CEO Alex Gorsky Takes the #EmbracingSustainability Challenge

A new Business Roundtable campaign is challenging America's top CEOs to shine a light on how they're doing their part to help improve the health of the environment.

Originally Published by Johnson & Johnson.

For more than 130 years, Johnson & Johnson has made it a mission to help keep people healthy. And since human health and environmental health are inextricably linked, the company is dedicated to helping keep the planet healthy, too.

Read More Show Less
REUTERS

Originally Published by Johnson & Johnson.

Johnson & Johnson Consumer, Inc. announced the company is joining an ambitious effort to move the world closer to a circular economy in which plastic never becomes waste. Together with the Ellen MacArthur Foundation, the UN Environment Programme, and many industry-leading companies, governments, and NGOs this commitment will strive to meet goals to tackle one of the most urgent environmental issues of our time: plastic waste and the necessity of consumer packaging reform.

Read More Show Less

Johnson & Johnson Human Performance Institute Expands Portfolio of C-suite Executive Development and Wellbeing Programs

The goal of Premier is to reinforce senior leaders and help them build personal resilience and character-centered leadership competencies that go beyond basic business skills-building.

REUTERS

Originally Published by Johnson & Johnson.

Johnson & Johnson Human Performance Institute (HPI) announced the expansion of its purpose-driven, character-centered executive development and wellbeing program, Premier Executive Leadership™ (Premier). HPI will now offer additional forms of its flagship Premier program, customized to cater to the unique needs and demands of the current, and next generation of global leaders. Gathering feedback and insights from CEOs, C-suite leaders and chief human resource officers around the globe, HPI uncovered an unmet need for highly personalized executive development programs that build and reinforce physical wellbeing, mental and emotional resilience, and character-centered leadership. This new offering expands upon the official launch of Premier last year.

Read More Show Less

Janssen Announces New Three-Year TREMFYA Data Demonstrates Stably Maintained Rates of Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis

At the three-year mark, patients receiving TREMFYA in clinical studies continue to show stably maintained PASI 90 and IGA 0/1 responses.

REUTERS

Originally Published by Johnson & Johnson.

The Janssen Pharmaceutical Companies of Johnson & Johnson announced new long-term data from the open-label period of the VOYAGE 1 clinical trial demonstrating that stably maintained rates of skin clearance with TREMFYA® treatment achieved from week 52 (1 year) were maintained through week 156 (3 years) among adult patients with moderate to severe plaque psoriasis. TREMFYA® is the first anti-interleukin (IL)-23 monoclonal antibody that was approved by the U.S. Food and Drug Administration (FDA) and is administered by subcutaneous injection. The findings, presented at the 37th Fall Clinical Dermatology Conference in Las Vegas, Nevada, showed nearly 83 percent of patients receiving TREMFYA® in the Phase 3 VOYAGE 1 study maintained at least a 90 percent improvement in the Psoriasis Area Severity Index (PASI 90) response (near complete skin clearance), and an Investigator's Global Assessment (IGA) score of cleared (0) or minimal disease (1) at week 156.

Read More Show Less

Johnson & Johnson: Nurse Innovators: The Change Agents of Healthcare

The launch of Campaign for Nursing's Future more than a decade ago helped address a dire nursing shortage. Now it wants to inspire nurses to be medical trailblazers.

REUTERS

Originally Pubished by Johnson & Johnson.

By Magdalena Puniewska

What words come to mind when you hear "nurse"?

Is it terms like "compassionate," "kind" and "comforting"? All of these are apt ways to describe the work that nurses do each and every day. But chances are you likely didn't think: "innovative."

Yet that's exactly what many nurses are—often unsung innovators. And Johnson & Johnson wants to help change that.

Read More Show Less

Where Will the Next Big Idea in Healthcare Come From? Johnson & Johnson is Counting on Nurses.

Johnson & Johnson Launches Nurses Innovate QuickFire Challenge to Bring Nurses' Ideas to Life.

REUTERS

Originally Published by Johnson & Johnson.

There's a reason the saying goes, "nurse someone back to health." Throughout history, nurses have been important facilitators of health – caring for the sick when others would not, identifying smarter and better ways to heal and developing life-saving methods.

Read More Show Less

Johnson & Johnson Announces 10-year Initiative to Help End Tuberculosis, the World's #1 Infectious Killer

J&J's goal is to save an estimated 1.8 million lives and prevent 12 million new TB infections.

REUTERS

Originally Published by Johnson & Johnson.

Ahead of the first-ever United Nations (UN) High-Level Meeting on Tuberculosis (TB), Johnson & Johnson yesterday announced a comprehensive 10-year initiative in support of the United Nations Sustainable Development Goal target of ending the TB pandemic by 2030. With the goal of saving an estimated 1.8 million lives and preventing 12 million new TB infections in the next decade, Johnson & Johnson will work with partners to improve detection of undiagnosed casesof TB, broaden access to its novel medicine for multidrug-resistant TB (MDR-TB), and accelerate research & development (R&D) to discover next-generation TB treatments.

Read More Show Less

Why Johnson & Johnson is on a Mission to Make Treating Pediatric Patients Safer

For Baby Safety Month, the company's Head of Pediatric Drug Development talks about the industry-leading Child Health Innovation Leadership Department.

REUTERS

Originally Published by Johnson & Johnson.

By Tamekia Reece

Ensuring the safety and well-being of children has been a cornerstone of Johnson & Johnson's work for over 100 years.

Today, the company helps provide treatments to millions of kids across the globe to address everything from tuberculosis to intestinal worm infections, so children can reach their full potential. It's just one facet of a larger commitment: help improve the health of future generations, or "GenH."

It's why Johnson & Johnson created the Child Health Innovation Leadership Department (CHILD), which is part of the company's Office of the Chief Medical Officer. The mission of CHILD is to help drive the creation of new and better policies around medical treatments for children, as well as uphold the safety and effectiveness of pediatric drugs.Another important facet of that commitment: help improve medical innovation for these little patients.

In honor of Baby Safety Month, we spoke to Samuel Maldonado, M.D., Head of Pediatric Drug Development and Vice President, Child Health Innovation Leadership Department, Johnson & Johnson, to learn more about the company's forward-thinking work for kids.

Read More Show Less
© Copyright 2018 — DiversityInc All Rights Reserved.